| CLP1144 |
|
1401708-83-5 |
N-((S)-1-(((2S,3S)-1-((6-氨基-6-氧代己基)氨基)-3-甲基-1-氧代戊烷-2-基)氨基)-3-(4-羥基苯基)-1-氧代丙烷-2-基)己酰胺 ;益智二肽
Dihexa (Synonyms: PNB-0408; N-hexanoic-Try-Ile-(6)-amino hexanoic amide; Hexanoyl-Tyr-Ile-Ahx-NH2)
-
98+%
|
需詢價 |
C27H44N4O5 |
|
|
|
| CL3074 |
|
928037-13-2 |
Golvatinib | E-7050
Golvatinib | E-7050
3-5days
98+%
|
￥288.00 |
C33H37F2N7O4 |
|
|
|
| CL2888 |
|
905854-02-6 |
(3R,4R) 替凡替尼 (ARQ 197), 肝細胞生長因子受體抑制劑 | 替萬替尼
Tivantinib | ARQ-197
-
98+%
|
需詢價 |
C23H19N3O2 |
|
|
|
| CL2448A |
|
1415560-69-8 |
鹽酸克里唑替尼
Crizotinib hydrochloride | PF-02341066 hydrochloride
3-5days
98+%
|
￥600.00 |
C21H23Cl3FN5O |
|
|
|
| CL2448 |
|
877399-52-5 |
(R)-3-(1-(2,6-二氯-3-氟苯基)乙氧基)-5-(1-(哌啶-4-基)-1H-吡唑-4-基)吡啶-2-胺;克唑替尼
Crizotinib (PF-02341066)
3-5days
98+%
|
￥450.00 |
C21H22Cl2FN5O |
|
|
|
| CLA1359 |
|
1365287-97-3 |
依瑪妥珠單抗
Emibetuzumab (Anti-HGFR / c-Met)
3-5days
95+%
|
￥2200.00 |
— |
|
|
|
| CLA1280 |
|
1174900-84-5 |
非拉妥組單抗
Ficlatuzumab (Anti-HGF / SF)
3-5days
95+%
|
￥3000.00 |
— |
|
|
|
| CLA1270 |
|
1133766-06-9 |
奧那妥組單抗
Onartuzumab (Anti-HGFR / c-Met)
3-5days
95+%
|
￥4500.00 |
— |
|
|
|
| CLA1225 |
|
872514-65-3 |
利妥木單抗
Rilotumumab (Anti-HGF / SF)
3-5days
95+%
|
￥3000.00 |
— |
|
|
|
| CL1800 |
|
943540-75-8 |
6-[二氟[6-(1-甲基-1H-吡唑-4-基)-1,2,4-三唑并[4,3-b]噠嗪-3-基]甲基]喹啉
JNJ-38877605 | JNJ 38877605
3-5days
98+%
|
￥568.00 |
C19H13F2N7 |
|
|
|
| CL2357 |
|
1022150-57-7 |
6-[[6-(1-甲基-1H-吡唑-4-基)-1,2,4-三唑并[4,3-b]噠嗪-3-基]硫基]喹啉
SGX-523
In-stock
98+%
|
￥288.00 |
C18H13N7S |
|
|
|
